Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Provenzano R, Besarab A, Sun CH, Diamond SA, Durham JH, Cangiano JL, Aiello JR, Novak JE, Lee T, Leong R, Roberts BK, Saikali KG, Hemmerich S, Szczech LA, Yu KH, Neff TB.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):982-91. doi: 10.2215/CJN.06890615. Epub 2016 Apr 19.

2.

Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease).

Szczech LA, Stewart RC, Su HL, DeLoskey RJ, Astor BC, Fox CH, McCullough PA, Vassalotti JA.

PLoS One. 2014 Nov 26;9(11):e110535. doi: 10.1371/journal.pone.0110535. eCollection 2014.

3.

Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.

McCullough PA, Barnhart HX, Inrig JK, Reddan D, Sapp S, Patel UD, Singh AK, Szczech LA, Califf RM.

Am J Nephrol. 2013;37(6):549-58. doi: 10.1159/000351175. Epub 2013 May 25.

4.

Patient and caregiver knowledge and utilization of partial versus radical nephrectomy: results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers.

Russo P, Szczech LA, Torres GS, Swartz MD.

Am J Kidney Dis. 2013 Jun;61(6):939-46. doi: 10.1053/j.ajkd.2013.01.028. Epub 2013 Mar 22.

PMID:
23523238
5.

A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation.

Vassalotti JA, Piraino B, Szczech LA.

Am J Kidney Dis. 2012 Nov;60(5):689-91. doi: 10.1053/j.ajkd.2012.08.013. No abstract available.

PMID:
23067630
6.

Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant?

Kutner NG, Zhang R, Szczech LA, Bliwise DL.

Nephrology (Carlton). 2012 Nov;17(8):783-4. doi: 10.1111/j.1440-1797.2012.01629.x. No abstract available.

PMID:
22713094
7.

Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.

Inrig JK, Barnhart HX, Reddan D, Patel UD, Sapp S, Califf RM, Singh AK, Szczech LA.

Am J Kidney Dis. 2012 Sep;60(3):390-401. doi: 10.1053/j.ajkd.2012.03.009. Epub 2012 Apr 25.

8.

Atrial fibrillation: the beat is faster than the answers.

Szczech LA.

Kidney Int. 2012 Mar;81(5):432-3. doi: 10.1038/ki.2011.430.

9.

Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.

Inrig JK, Bryskin SK, Patel UD, Arcasoy M, Szczech LA.

BMC Nephrol. 2011 Dec 12;12:67. doi: 10.1186/1471-2369-12-67.

10.

Veterans more likely to start hemodialysis with an arteriovenous fistula.

Parikh DS, Inrig JK, Kipp A, Szczech LA, McClellan W, Patel UD.

Semin Dial. 2011 Sep-Oct;24(5):570-5. doi: 10.1111/j.1525-139X.2011.00920.x. Epub 2011 Sep 13.

PMID:
21913987
11.

Where is Walter--if he isn't in my office, is he really my responsibility? The 2011 National Kidney Foundation Presidential Address.

Szczech LA.

Am J Kidney Dis. 2011 Apr;57(4):529-31. doi: 10.1053/j.ajkd.2011.01.016. No abstract available.

PMID:
21421134
12.

Chronic kidney disease anemia management: what should be done?

Szczech LA.

Blood Purif. 2011;31(1-3):186-8. doi: 10.1159/000321852. Epub 2011 Jan 10.

13.

Getting the urine to the lab: time to think outside of the specimen cup.

Szczech LA.

Kidney Int. 2011 Jan;79(2):145-7. doi: 10.1038/ki.2010.401.

14.

Tackling the unknowns in HIV-related kidney diseases.

Szczech LA.

N Engl J Med. 2010 Nov 18;363(21):2058-9. doi: 10.1056/NEJMe1010940. No abstract available.

PMID:
21083392
15.

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.

Choi A, Scherzer R, Bacchetti P, Tien PC, Saag MS, Gibert CL, Szczech LA, Grunfeld C, Shlipak MG.

Am J Kidney Dis. 2010 Nov;56(5):872-82. doi: 10.1053/j.ajkd.2010.05.019. Epub 2010 Aug 14.

16.

Hypothesis: an erythropoietin honeymoon phase exists.

Fishbane S, Miyawaki N, Szczech LA.

Kidney Int. 2010 Oct;78(7):646-9. doi: 10.1038/ki.2010.233. Epub 2010 Jul 14. Review. Erratum in: Kidney Int. 2010 Dec;78(12):1322.

17.

Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.

Cramer YS, Rosenkranz SL, Hall SD, Szczech LA, Amorosa V, Gupta SK.

J Acquir Immune Defic Syndr. 2010 Aug;54(4):e7-9. doi: 10.1097/QAI.0b013e3181e2d5e5. No abstract available.

18.

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):217-20. doi: 10.1097/QAI.0b013e3181e674f4.

20.

Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.

Szczech LA, Bregman DB, Harrington RA, Morris D, Butcher A, Koch TA, Goodnough LT, Wolf M, Onken JE.

Nephrol Dial Transplant. 2010 Jul;25(7):2368-75. doi: 10.1093/ndt/gfq218. Epub 2010 Apr 21.

PMID:
20466657
21.

Acute kidney injury and cardiovascular outcomes in acute severe hypertension.

Szczech LA, Granger CB, Dasta JF, Amin A, Peacock WF, McCullough PA, Devlin JW, Weir MR, Katz JN, Anderson FA Jr, Wyman A, Varon J; Studying the Treatment of Acute Hypertension Investigators.

Circulation. 2010 May 25;121(20):2183-91. doi: 10.1161/CIRCULATIONAHA.109.896597. Epub 2010 May 10.

PMID:
20458014
22.

Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA.

Parikh DS, Swaminathan M, Archer LE, Inrig JK, Szczech LA, Shaw AD, Patel UD.

Nephrol Dial Transplant. 2010 Jul;25(7):2275-83. doi: 10.1093/ndt/gfp781. Epub 2010 Jan 26.

23.

Microalbuminuria predicts overt proteinuria among patients with HIV infection.

Szczech LA, Menezes P, Byrd Quinlivan E, van der Horst C, Bartlett JA, Svetkey LP.

HIV Med. 2010 Aug;11(7):419-26. doi: 10.1111/j.1468-1293.2009.00805.x. Epub 2010 Jan 4.

24.

Did 'renalism' skew the results of a negative study?

Szczech LA.

Nat Rev Nephrol. 2010 Jan;6(1):18-20. doi: 10.1038/nrneph.2009.208. No abstract available.

PMID:
20023688
25.

Management of HIV-infected patients with ESRD.

Novak JE, Szczech LA.

Adv Chronic Kidney Dis. 2010 Jan;17(1):102-10. doi: 10.1053/j.ackd.2009.08.014. Review.

PMID:
20005494
26.

HIV through a nephrologist's lens.

Novak JE, Szczech LA.

Adv Chronic Kidney Dis. 2010 Jan;17(1):3-4. doi: 10.1053/j.ackd.2009.07.012. No abstract available.

PMID:
20005483
27.

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.

Szczech LA, Barnhart HX, Sapp S, Felker GM, Hernandez A, Reddan D, Califf RM, Inrig JK, Patel UD, Singh AK.

Kidney Int. 2010 Feb;77(3):239-46. doi: 10.1038/ki.2009.415. Epub 2009 Nov 4.

28.

Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes.

Inrig JK, Patel UD, Toto RD, Reddan DN, Himmelfarb J, Lindsay RM, Stivelman J, Winchester JF, Szczech LA.

Kidney Int. 2009 Nov;76(10):1098-107. doi: 10.1038/ki.2009.340. Epub 2009 Sep 2.

29.

Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.

Eisenstein EL, Sun JL, Anstrom KJ, DeLong ER, Szczech LA, Mark DB.

J Med Syst. 2009 Aug;33(4):287-97.

30.
31.

Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.

Gupta SK, Komarow L, Gulick RM, Pollard RB, Robbins GK, Franceschini N, Szczech LA, Koletar SL, Kalayjian RC.

J Infect Dis. 2009 Aug 15;200(4):614-8. doi: 10.1086/600890.

32.

Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: con.

Himmelfarb J, Szczech LA.

J Am Soc Nephrol. 2009 Jul;20(7):1441-3. No abstract available.

33.

The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.

Gupta SK, Smurzynski M, Franceschini N, Bosch RJ, Szczech LA, Kalayjian RC; AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Study Team.

Antivir Ther. 2009;14(4):543-9.

34.

Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Szczech LA.

Curr Opin HIV AIDS. 2009 May;4(3):167-70. doi: 10.1097/COH.0b013e328329c646. Review.

PMID:
19532045
35.

The development of urinary biomarkers for kidney disease is the search for our renal troponin.

Szczech LA.

J Am Soc Nephrol. 2009 Aug;20(8):1656-7. doi: 10.1681/ASN.2009050525. Epub 2009 Jun 11. No abstract available.

36.

World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease.

Szczech LA, Harmon W, Hostetter TH, Klotman PE, Powe NR, Sedor JR, Smedberg P, Himmelfarb J.

J Am Soc Nephrol. 2009 Mar;20(3):453-5. doi: 10.1681/ASN.2009010041. Epub 2009 Feb 25. No abstract available.

37.

Do income level and race influence survival in patients receiving hemodialysis?

Eisenstein EL, Sun JL, Anstrom KJ, Stafford JA, Szczech LA, Muhlbaier LH, Mark DB.

Am J Med. 2009 Feb;122(2):170-80. doi: 10.1016/j.amjmed.2008.08.025.

PMID:
19185093
38.

Acute kidney injury in HIV-infected patients.

Kalim S, Szczech LA, Wyatt CM.

Semin Nephrol. 2008 Nov;28(6):556-62. doi: 10.1016/j.semnephrol.2008.08.008. Review.

39.

Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.

Novak JE, Szczech LA.

Semin Dial. 2009 Jan-Feb;22(1):56-63. doi: 10.1111/j.1525-139X.2008.00514.x. Epub 2008 Oct 16. Review.

PMID:
19000107
40.

Triumph and tragedy: anemia management in chronic kidney disease.

Novak JE, Szczech LA.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. doi: 10.1097/MNH.0b013e32830c488d. Review.

PMID:
18941350
41.

Renal dysfunction and tenofovir toxicity in HIV-infected patients.

Szczech LA.

Top HIV Med. 2008 Oct-Nov;16(4):122-6. Review.

42.

HIV-related renal disease and the utility of empiric therapy: not everyone needs to be biopsied.

Szczech LA.

Nat Clin Pract Nephrol. 2009 Jan;5(1):20-1. doi: 10.1038/ncpneph0969. Epub 2008 Sep 30. Review. No abstract available.

PMID:
18825153
43.

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.

Gupta SK, Rosenkranz SL, Cramer YS, Koletar SL, Szczech LA, Amorosa V, Hall SD.

AIDS. 2008 Oct 1;22(15):1919-27. doi: 10.1097/QAD.0b013e32830e011f.

44.

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Sapp S, Califf RM, Patel UD, Singh AK.

Kidney Int. 2008 Sep;74(6):791-8. doi: 10.1038/ki.2008.295. Epub 2008 Jul 2.

45.

Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression.

Hedayati SS, Bosworth HB, Briley LP, Sloane RJ, Pieper CF, Kimmel PL, Szczech LA.

Kidney Int. 2008 Oct;74(7):930-6. doi: 10.1038/ki.2008.311. Epub 2008 Jun 25.

46.

Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection.

Szczech LA, Golub ET, Springer G, Augenbraun M, Young M, Gandhi M, Gillepsie BS, Anastos K.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):360-1. doi: 10.1097/QAI.0b013e31817beba1. No abstract available.

PMID:
18580338
47.

Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States.

Shea AM, Curtis LH, Szczech LA, Schulman KA.

BMC Nephrol. 2008 Jun 18;9:5. doi: 10.1186/1471-2369-9-5.

48.

Negative trials in nephrology: what can we learn?

Novak JE, Inrig JK, Patel UD, Califf RM, Szczech LA.

Kidney Int. 2008 Nov;74(9):1121-7. doi: 10.1038/ki.2008.286. Epub 2008 Jun 18. Review.

49.

Re-evaluating the volume-outcome relationship in hemodialysis patients.

Eisenstein EL, Sun JL, Anstrom KJ, Stafford JA, Szczech LA, Muhlbaier LH, Mark DB.

Health Policy. 2008 Dec;88(2-3):317-25. doi: 10.1016/j.healthpol.2008.03.017. Epub 2008 May 27.

PMID:
18502534
50.

Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease.

Melloni C, Alexander KP, Milford-Beland S, Newby LK, Szczech LA, Pollack CV, Kirk JD, Christenson RH, Harrington RA, Gibler WB, Ohman EM, Peterson ED, Roe MT; Crusade Investigators.

Clin Cardiol. 2008 Mar;31(3):125-9. doi: 10.1002/clc.20210.

Supplemental Content

Loading ...
Support Center